D. Frappaz
AuthID: R-00G-MES
1
TÃTULO: European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
AUTORES: van den Bent, MJ; Grisold, W; Frappaz, D; Stupp, R; Desir, JP; Lesimple, T; Dittrich, C; de Jonge, MJA; Brandes, A; Frenay, M; Carpentier, AE; Chollet, P; Oliveira, J; Baron, B; Lacombe, D; Schuessler, M; Fumoleau, P;
PUBLICAÇÃO: 2003, FONTE: 93rd Annual Meeting of the American-Association-for-Cancer-Research in ANNALS OF ONCOLOGY, VOLUME: 14, NÚMERO: 12
AUTORES: van den Bent, MJ; Grisold, W; Frappaz, D; Stupp, R; Desir, JP; Lesimple, T; Dittrich, C; de Jonge, MJA; Brandes, A; Frenay, M; Carpentier, AE; Chollet, P; Oliveira, J; Baron, B; Lacombe, D; Schuessler, M; Fumoleau, P;
PUBLICAÇÃO: 2003, FONTE: 93rd Annual Meeting of the American-Association-for-Cancer-Research in ANNALS OF ONCOLOGY, VOLUME: 14, NÚMERO: 12
